↓ Skip to main content

Dove Medical Press

Article Metrics

Aripiprazole combination for reversal of paliperidone-induced increase in prolactin level

Overview of attention for article published in Neuropsychiatric Disease and Treatment, August 2018
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 tweeter
facebook
1 Facebook page

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
9 Mendeley
Title
Aripiprazole combination for reversal of paliperidone-induced increase in prolactin level
Published in
Neuropsychiatric Disease and Treatment, August 2018
DOI 10.2147/ndt.s167129
Pubmed ID
Authors

Pu Zhi, Yanqiong Wang, Wei Quan, Yanli Su, Hui Zhang

Abstract

Hyperprolactinemia is a common side effect of antipsychotic drugs. Although changes of antipsychotic drugs or reduction of their doses can solve this problem, a modification of the treatment regimen can lead to instability in patients. Herein, we followed up a patient with elevated prolactin caused by paliperidone and found that the prolactin level was decreased after the administration of a combination with a low-dose aripiprazole. In addition, we summarized and analyzed the findings from the case and the literature review conducted.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 9 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 9 100%

Demographic breakdown

Readers by professional status Count As %
Other 2 22%
Student > Bachelor 2 22%
Student > Master 1 11%
Researcher 1 11%
Student > Postgraduate 1 11%
Other 0 0%
Unknown 2 22%
Readers by discipline Count As %
Medicine and Dentistry 3 33%
Social Sciences 1 11%
Physics and Astronomy 1 11%
Business, Management and Accounting 1 11%
Neuroscience 1 11%
Other 0 0%
Unknown 2 22%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 August 2018.
All research outputs
#11,040,555
of 14,537,474 outputs
Outputs from Neuropsychiatric Disease and Treatment
#1,732
of 2,487 outputs
Outputs of similar age
#189,172
of 273,679 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#32
of 58 outputs
Altmetric has tracked 14,537,474 research outputs across all sources so far. This one is in the 20th percentile – i.e., 20% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,487 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.0. This one is in the 25th percentile – i.e., 25% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 273,679 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 58 others from the same source and published within six weeks on either side of this one. This one is in the 36th percentile – i.e., 36% of its contemporaries scored the same or lower than it.